That is a fair assessment. Remember just a few months ago MSB was 'fully funded to cash flow', this has obviously changed and one has to ask why. Lack of a deal? Slower approvals? Lower expected initial income from GvHD? Unexpected trial expenses? I think those who have done their research will know the answer/s.
I agree the upcoming ph 3 results will be game changing. Hopefully to the up side but who knows...
The number of times you said might, may, talked about, potential, would, can still be.... does not exactly inspire conviction.
I have said time and time again that msb is speculative and high risk. I will personally wait for solid foundations before I commit to a real long term investment.
MSB Price at posting:
$3.41 Sentiment: None Disclosure: Not Held
(20min delay)